CL. Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy. J Appl Physiol 118: 941-952, 2015. First published February 6, 2015 doi:10.1152/japplphysiol.00886.2014.-Spinal and bulbar muscular atrophy (SBMA) is characterized by progressive muscle weakness linked to a polyglutamine expansion in the androgen receptor (AR). Current evidence indicates that mutant AR causes SBMA by acting in muscle to perturb its function. However, information about how muscle function is impaired is scant. One fundamental question is whether the intrinsic strength of muscles, an attribute of muscle independent of its mass, is affected. In the current study, we assess the contractile properties of hindlimb muscles in vitro from chronically diseased males of three different SBMA mouse models: a transgenic (Tg) model that broadly expresses a full-length human AR with 97 CAGs (97Q), a knock-in (KI) model that expresses a humanized AR containing a CAG expansion in the first exon, and a Tg myogenic model that overexpresses wild-type AR only in skeletal muscle fibers. We found that hindlimb muscles in the two Tg models (97Q and myogenic) showed marked losses in their intrinsic strength and resistance to fatigue, but were minimally affected in KI males. However, diseased muscles of all three models showed symptoms consistent with myotonic dystrophy type 1, namely, reduced resting membrane potential and deficits in chloride channel mRNA. These data indicate that muscle dysfunction is a core feature of SBMA caused by at least some of the same pathogenic mechanisms as myotonic dystrophy. Thus mechanisms controlling muscle function per se independent of mass are prime targets for SBMA therapeutics.
SPINAL AND BULBAR MUSCULAR ATROPHY (SBMA) is a late-onset motoneuron disease that leads to profound muscle weakness and fatigue (14) . This disease affects only men, tends not be fatal, and is linked to a CAG expansion mutation in the first exon of the androgen receptor (AR) gene (11, 27) . While muscle weakness and fatigue have historically been attributed to a neurogenic cause, i.e., caused by a loss of innervation, recent evidence indicates that muscle function may be impaired directly by ARs in skeletal muscles (7, 28, 34) . However, despite this growing appreciation that dysfunction in skeletal muscles may underlie motor dysfunction, information about how muscle function per se is affected in SBMA is scant.
When SBMA patients report difficulties with fatigue and muscle strength, such symptoms could be caused by defects in the nerve, at the neuromuscular junction and/or in the skeletal muscle itself. Because muscles atrophy in SBMA, the inclination is to attribute the loss of strength solely to a loss in muscle mass. However, this need not be the case. Recent evidence indicates that nerve conduction in SBMA patients can be impaired (12, 36) , leading to compromised activation of the muscles. Nonetheless, because larger muscles are stronger than smaller muscles (when all else is equal), atrophic muscles in SBMA patients are undoubtedly weaker when activated. What is less clear, however, is whether diseased muscles are also weak over and above their reduced mass, referred to as the intrinsic strength of skeletal muscle. If the intrinsic strength of muscles is also reduced in SBMA, then this would suggest new therapeutic targets for treating SBMA that control strength rather than mass.
Previous work in our lab suggests that mutant AR in skeletal muscles of SBMA patients likely causes muscle dysfunction. This conclusion is based on a muscle-specific transgenic (Tg) mouse model of SBMA, which we refer to as the myogenic model. This model overexpresses wild-type (WT) AR only in muscle fibers but nonetheless recapitulates the SBMA phenotype (34) . A powerful aspect of this model is that females carrying the transgene have normal motor function until exposed to male levels of androgen. Androgens trigger a rapid collapse in motor function, which is accompanied by a corresponding collapse in muscle function. After only 5 days of androgen treatment, isolated muscles produce less than 50% of their original force, a loss that occurs independent of muscle mass (38) . Indeed, muscle mass is unaffected in this model, arguing that neurogenic atrophy cannot explain the loss in muscle strength. However, whether muscles of diseased SBMA male mice are similarly affected has not been determined.
In the current study, we directly assessed the in vitro strength properties of slow-twitch and fast-twitch hindlimb muscles from motor-impaired male mice of three genetically distinct SBMA models: the myogenic model, the 97Q Tg model in which a full-length human AR with 97 CAGs/ polyglutamines (polyQ) is globally expressed (22) , and the knock-in (KI) model which expresses a humanized polyQexpanded mouse allele of AR (53) . Despite such differences, all three models exhibit core features of SBMA in humans:
only male mice expressing the disease allele lose motor function, a loss that can be reversed by eliminating gonadal androgens. We now report that mechanisms controlling the intrinsic strength of muscles are markedly defective in the two Tg models, 97Q and myogenic, but only marginally affected in KI males. However, because muscles of KI males exhibit some of the same pathological traits as muscles affected by the myogenic disease myotonic dystrophy type 1 (DM1), including hyperexcitability and chloride channel defects (53), we examined whether 97Q and myogenic males also show such pathological traits. Hyperexcitability of muscle fibers is associated with a reduced (more depolarized) resting membrane potential caused by a deficit in membrane chloride channels (30) . We found that both the resting membrane potential of muscle fibers and chloride channel mRNA expression in muscles of all three models showed defects consistent with a DM1 phenotype. These findings suggest that similar core defects may exist in muscles of SBMA patients. Future work aimed at identifying the molecular mechanisms underlying primary muscle dysfunction in SBMA is likely to suggest novel therapeutic targets to treat this disease.
MATERIALS AND METHODS

Animals and Treatment
The contractile properties of the fast-twitch extensor digitorum longus (EDL) and the slow-twitch soleus (SOL) muscles of affected male mice from three different models of SBMA were examined: the myogenic model (line 141) (34) , the 97Q Tg model (22) , and the KI model (53) . Heterozygous female carriers of each model were mated with C57/B6J male mice for over 10 generations to produce progeny for this study. Animals were group housed and had access to water and food ad libitum. All animal procedures were approved and performed in compliance with the Michigan State University Institutional Animal Care and Use Committee, in accordance with the standards in the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
97Q males. Because disease onset is highly variable in Tg 97Q males, we attempted to synchronize disease onset and progression by exposing castrated juvenile males to adult levels of testosterone. Age-matched (30 -32 days old) WT and Tg male mice (n ϭ 5-6 mice/group) were deeply anesthetized with isoflurane, castrated, and implanted subcutaneously with Silastic capsules containing crystalline testosterone or nothing, as previously described (20) . All animals received ketoprofen analgesic (5 mg/kg sc) immediately following surgery. Treatment was continued until Tg males reached end-stage motor function, as detailed below.
Motor function was assessed using the grip strength and hang tests 1 h before surgery to establish baseline performance (Day 0) and twice weekly following surgery up to the time of end-stage motor function, defined as hang times Ͻ24 s or 20% of the latency to fall of age-matched WT controls and grip strengths Յ16 g of force, roughly one-half of the WT control values. Testosterone-treated Tg mice reached end stage by around 50 days of age, at which time mice were overdosed with sodium pentobarbital and muscles were harvested for in vitro tension measures as previously described (38) .
141 Myogenic males. Normally, most males in the myogenic model die on the day of birth (34) . However, prenatal exposure to the AR antagonist flutamide rescues many such Tg males (19, 34) . Notably, such flutamide-rescued Tg males show the same androgen-dependent disease phenotype as Tg male mice that survived without the aid of prenatal flutamide (19) . Thus, timed pregnant Tg dams were given daily sc injections of flutamide (5 mg flutamide dissolved in 100 l propylene glycol) on gestational days 14 -18. Postnatally, animals received standard care with no further treatment. As adults (90 -135 days old), the motor function of Tg and age-matched WT controls (n ϭ 5-6 mice/group), both exposed to the same prenatal flutamide regime, was assessed based on the grip strength and hang tests. Because Tg males in this model are chronically impaired from an early stage, motor function was assessed starting 3 days before muscle harvest, and reported values are those taken on the last day just before muscle harvest.
KI males. The length of CAG repeat in the AR gene of the KI model tends to contract across generations, necessitating sequencing the first exon to determine the length of the repeat and, thus, the potential for toxicity. KI males used in this study had a repeat length ranging from 84 to 93. The motor function of KI male mice and WT controls (n ϭ 5-7/group) was measured starting at 30 days of age and then twice weekly based on the grip strength and hang tests until a Ն30% decline was seen on one or both tests in KI males, at which point muscles were harvested for in vitro examination. Muscle function from diseased males was always compared with age-matched WT controls obtained from the same colony and often the same litter.
Motor Function Tests
In the 97Q and 141 lines, forelimb grip strength was assessed using the grid pull bar of a grip strength meter (Columbus Instruments, Columbus, OH) oriented in the horizontal plane (5, 20, 23) . The triangular pull bar was used to measure grip strength for mice in the KI model, because deficits are more easily detected in this model using this bar (24, 53) .
The hang test for all three models was conducted by placing mice on a wire grid that was then rotated 180 degrees 40 cm above a counter. Latency to fall (up to 120 s) from the wire grid was measured (34, 45) .
The number of rears (i.e., number of vertical movements) was also assessed in an open field (16 ϫ 16 inch Plexiglas chamber) for 5 min using the Versamax activity monitor (AccuScan Instruments, Columbus, OH). The chamber was cleaned with 70% ethanol between tests, and data were analyzed using Versamax software (20) . Rearing behavior is an indirect readout of hindlimb muscle strength and was conducted in the 97Q and 141 models. Rearing behavior in the KI model was not assessed, because previous extensive testing failed to reveal a deficit in rearing ability in this model (C. L. Jordan, unpublished observations).
In Vitro Studies To Assess Muscle Mechanics
Contractile characteristics of the isolated fast-twitch EDL and slow-twitch SOL were assessed from chronically diseased and WT males in vitro as previously described (38) . All aspects of the stimulation regime matched what is detailed in this earlier report. Reasons for selecting these hindlimb muscles include that the EDL and SOL are the prototypical fast-and slow-twitch muscles, respectively, with considerable background information available on their normal contractile properties (8, 26) , and that the effects of disease often depend on the specific fiber type composition of the muscle (1), as we also found in an acute model of SBMA (38) .
Resistance to fatigue was also assessed in the EDL and SOL muscles, using the same parameters of tetanic stimulation as previously described (17, 38) . The fatigue profile was determined by generating a curve that calculated the amount of force produced at each stimulus pulse relative to muscle mass. Following the experiment, muscles were rapidly removed from the apparatus, dissected free from tendons, blotted of excess media, weighed to estimate mass, and then stored at Ϫ80°C.
Histology
In the myogenic model, the contralateral SOL was dissected and snap frozen in OCT compound in cryomolds and stored at Ϫ80°C for later histological analysis (n ϭ 5 mice/group). The EDL in this model had been previously examined (20) . The SOL was cross-sectioned on a Leica cryostat at 10 m, thaw-mounted onto gel-subbed slides, and stained with hematoxylin and eosin. Both the EDL and SOL from 97Q males and WT controls were prepared the same way for histological analyses. Because our goal was to relate structure to function and we did not find any significant deficits in the contractile properties of either the EDL or SOL muscles of KI males, the muscles in this model were not examined for histopathology.
Intracellular Recording
Mice were killed by decapitation following anesthesia with carbon dioxide inhalation. The EDL muscle (for the Tg models) and the levator ani (for the KI model) with its attached nerve were dissected under oxygenated (100% O 2) physiological saline solution (135 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 14 mM HEPES, 11 mM glucose, pH at 7.4). For recording, the tissue was pinned out at resting tension in a Sylgard-coated chamber and perfused continuously at a rate of 1-5 ml/min with oxygenated physiological saline at room temperature (23-25°C). Intracellular glass microelectrodes (1.0 mm outer diameter; WPI, Sarasota, FL) for measuring resting membrane potential had a resistance of 5-15 M⍀ when filled with 3 M KCl. Signals were amplified using an Axoclamp-2A (Molecular Devices, Sunnyvale, CA), acquired with Clampex version 9.2 by using an analog-to-digital converter (DigiData; Axon Instruments). Off-line analysis was performed with Clampfit version 9.2. Different cohorts of mice were used for the intracellular recording studies, with muscles harvested from impaired Tg and KI mice and age-matched WT controls. In this case, 97Q males were gonadally intact, with motor deficits naturally emerging during puberty as previously reported (22) .
Quantitative Real-Time PCR Assay
EDL muscles were harvested from both limbs of myogenic and 97Q males and their respective WT controls, whereas the ARenriched bulbocavernosus/levator ani was harvested from KI and WT control males under deep isoflurane anesthesia. Tissue was weighed fresh and immediately frozen in RNase-free tubes on dry ice, and held at Ϫ80°C until processed. All instruments were sprayed with RNaseZap (Sigma-Aldrich) between animal harvests. Different cohorts of mice were used for these studies, with muscles harvested from impaired Tg and KI mice and age-matched WT controls. 97Q males and aged-matched WT controls were again gonadally intact.
RNA was extracted from muscles using an RNeasy fibrous tissue mini-kit (Qiagen, Valencia, CA). The tissue was mechanically homogenized with a PRO200 homogenizer (Pro Scientific, Oxford, CT). Following extraction, RNA was quantified on a spectrophotometer (Beckman DU 530, Pasadena, CA) by measuring 260 nm absorbance values. RNA was then reverse transcribed using a high-capacity cDNA reverse transcription kit (Applied Biosystems) with the following thermocycle: 25°C for 10 min, 37°C for 2 h, and 85°C for 5 min. The master mix for the quantitative real-time PCR (RT-qPCR) assay included 2.5 ng of cDNA, primers, and Power SYBR Green PCR Master Mix (Applied Biosystems Carlsbad CA). The thermocycle for the quantitative step on the ABI PRISM 7000 Sequence Detection System was as follows: 50°C for 2 min, 95°C for 10 min, and 40 cycles of 95°C for 15 s and 60°C for 1 min. A dissociation curve was determined for each well to confirm that the correct gene was being amplified. Each sample was run in triplicate. Samples without reverse transcriptase during the cDNA conversion were also assessed to ensure that there was no DNA contamination. The reference gene was 18S (100 nM primers: GGACCAGAGCGAAAGCATTTG and GC-CAGTCGGCATCGTTTATG; TTGACGGAAGGGCACCACCAG and GCACCACCACCCACGGAATCG). The 18S primers were chosen for each model by confirming that they do not change between genotypes. Chloride channel primers were as follows: 200 nM, GATTTGCTGCGGGTTCTTGG and TGGCTGAGACACTTGT-GCTT. Amplification efficiencies were calculated for each primer set.
A relative expression software tool was used to assess statistical significance and times change of genes (41) . Specifically, this software uses the nonparametric pairwise fixed reallocation randomization test to account for amplification efficiencies when determining times change. It measures relative expression of CLCN1 between two groups of animals following the normalization of a target gene (CLNC1) to a reference gene (18S).
Testosterone Levels
Blood was collected via a transcardial puncture from deeply anesthetized mice used for studies on muscle mechanics, and held on ice for 30 min before centrifuging at 3,000 rpm for 20 min at 8°C (Sorvall Biofuge Fresco; Thermo Scientific, Asheville, NC). After centrifugation of blood samples, plasma was collected and held at Ϫ80°C until assayed for circulating testosterone levels as previously described (55) .
Data Analysis and Statistics
Analysis of mechanical transients was performed using a custom algorithm created for the MatLab programming environment (Mathworks, Natick, MA) as done previously (38) using a low-pass filter to smooth raw data before analysis of force output and tension-time integrals. Kinetic parameters for the rise time (time to peak force) and relaxation time (time of return to baseline) were also measured in individual muscle twitches as previously described (38) . Fatigue resistance was quantified based on the time it took to reach a 50% drop from the starting tension. Independent groups T-tests were used to evaluate significant differences between muscles from affected Tg or KI males and their WT controls unless otherwise indicated.
RESULTS
Motor Dysfunction Correlates With Muscle Dysfunction in 97Q Tg Mice
Motor tests confirmed that castrated 97Q Tg males treated with testosterone show the same androgen-dependent decline of motor function as previously reported for gonadally intact 97Q Tg males (22) . All three indices of motor function, i.e., number of rears in an open field (Fig. 1A) , front paw grip strength (Fig. 1B) , and hang times (Fig. 1C) , indicate that the motor function of 97Q Tg males was significantly impaired compared with WT controls after 10 -25 days of testosterone exposure (40 -57 days old; P Յ 0.002). Serum testosterone levels were comparable between Tg and WT controls, indicating that deficits in motor function in Tg males were not due to differences in circulating testosterone ( Table 1 ). The testosterone treatment did, however, result in higher than normal levels of testosterone for both Tg and WT males compared with gonadally intact males in the other two models (e.g., compare to testosterone levels for 141 males), likely due to their lower body weights (Table 1) . Importantly, deficits in body weight lagged behind deficits in motor function by ϳ3 days (data not shown).
Both the isolated EDL and SOL muscles from 97Q males showed significant deficits in force for both raw and normalized measures (Fig. 2) . With one exception (raw tetanic force in SOL, Fig. 2J ), raw twitch and tetanic force were significantly decreased in muscles of 97Q Tg males compared with WT males (P Յ 0.007 for raw EDL twitch and tetanus and raw SOL twitch). However, once force measures for individual muscles were normalized to their mass, all force measures for both muscles from Tg males showed significant and robust deficits (P Յ 0.002 for all comparisons), indicating that disease Contractile Dysfunction Underlies Motor Dysfunction in SBMA • Oki K et al. caused a loss of force that is independent of the loss in muscle mass in both fast-and slow-twitch muscles in 97Q males. Notably, the Tg EDL shows a greater normalized force deficit (based on both normalized twitch and tetanic force) than the Tg SOL, producing Ͻ20% of normal WT force, for both twitch and tetanus, whereas the Tg SOL produces ϳ50% of WT twitch force and ϳ70% of tetanic WT force. These data support the idea that a loss of motor function may be due to a loss in contractile force of muscles, some of which reflects muscle atrophy, but much of which is independent of muscle mass. We found no evidence of a drop in force production from the first to the last recording of peak tetanic tension (data not shown). This apparent stability of muscle performance in vitro strongly argues that the force deficits reflect genuine deficits in vivo.
Although relatively more force was lost in the Tg EDL than Tg SOL, only the Tg SOL shows a significant decrease in the twitch-to-tetanus ratio (Fig. 2L ) compared with WT (P Ͻ 0.02). The diseased EDL did, however, show a similar trend (Fig. 2F) . These data suggest impairments in calcium handling mechanisms in the SOL and possibly the EDL muscles of motor-impaired 97Q Tg males.
Twitch traces (Fig. 2, C and I ) were subjected to a kinetics analysis to assess whether time to peak force (rise time) and time to baseline (relaxation time) were also affected by disease. Although both contraction and relaxation times were consistently longer in Tg muscles than WT controls, such differences fell short of significance (Table 2) .
When muscles were stimulated to induce fatigue, data suggested that 97Q EDL was more resistant to fatigue than the WT EDL (Fig. 3A) , i.e., the EDL from Tg males lost less force over the stimulation period than did WT EDL (45% force loss in Tg vs. 92% force loss in WT). However, we suspect that the low starting tension of the Tg EDL limited our ability to accurately detect fatigue as reflected in a wholesale drop in tension. When we determined the time it took for muscles to lose 50% of their original force (i.e., time to half-maximal force loss), we found that the EDL from Tg males fatigued faster, reaching a 50% drop in force twice as fast as WT EDL (Fig. 3B , P Ͻ 0.05). The SOL from Tg males showed a similar increase in fatigue susceptibility, losing 50% of its original force significantly sooner than WT SOL (P Ͻ 0.05), but the effect of disease on fatigability in the SOL seems much less marked than in the EDL (Fig. 2, C and D) .
Motor Dysfunction Correlates With Muscle Dysfunction in Myogenic (141) Tg Males
As expected, 141 Tg mice also exhibited profoundly compromised motor function, showing deficits on all three measures: rearing, grip strength, and hang times (Fig. 1, D-F ; P Ͻ 0.001 for all tests). These data confirm findings from previous studies (19, 34) . Body and muscle weights were also decreased in myogenic males compared with WT, but serum testosterone levels were comparable ( Table 1 ), indicating that abnormal testosterone levels do not explain the motor phenotype in 141 Tg male mice.
The EDL and SOL muscles of diseased 141 Tg males also show marked deficits in muscle force (Fig. 4) , with both muscles showing significant deficits compared with WT muscles in both raw twitch and raw tetanic force production (P Ͻ 0.001). Significant deficits were also evident once force was normalized (Fig. 4 , B, H, and K), with the one exception that tetanic force in the Tg EDL was no longer less than in WT controls (Fig. 4, D vs. E) . Given that the EDL from chronically impaired Tg males contains about 30% fewer fibers than normal (19), we suspect that this deficit in fiber number underlies the deficit in raw tetanic force and that the maximal Values are means Ϯ SE. Body weight, muscle mass, and plasma testosterone (T) levels at end stage of the disease for transgenic (Tg) males and their corresponding wild-type (WT) controls of two different (97Q and myogenic) spinal and bulbar muscular atrophy (SBMA) models. EDL, extensor digitorum longus; SOL, soleus. *P Յ 0.05 difference between transgenic mice and their respective WT controls. contractile force produced by each fiber is comparable to that of WT fibers. Because the normalized twitch but not normalized tetanic force was affected in the Tg EDL, the twitch-totetanus ratio in this muscle was also significantly reduced (P Ͻ 0.005) to about one-half that of WT muscle (Fig. 4F) , again implicating dysfunction in the mechanisms controlling calcium fluxes within muscle fibers. The twitch-to-tetanus ratio was also significantly decreased in the TG SOL, although the magnitude of the effect was less than for the EDL (Fig. 4L) . In short, both EDL and SOL muscles in diseased myogenic males showed a marked loss of intrinsic contractile strength similar to 97Q males, although fiber type differences were evident between the two models. We again found no evidence of a drop in force production from the first to the last recording of peak tetanic tension (data not shown) prior to the fatiguing stimulation.
Our analysis of twitch kinetics reveals that only the rise time of twitches in myogenic EDL was significantly prolonged compared with normal (Table 2 ; P Ͻ 0.001). Relaxation time in the EDL was not affected by disease, and contraction and relaxation times were not affected in the SOL of myogenic Tg males.
During fatiguing stimulation, the EDL from myogenic males lost less force overall than the WT EDL (71% force loss in Tg vs. 95% in WT; Fig. 5A ), suggesting that the Tg EDL had greater endurance than the WT EDL, consistent with an apparent shift toward a more oxidative phenotype in diseased EDL (34) . However, the time it took to reach a 50% drop in force was the same for Tg and WT EDL muscles (Fig. 5B) . The fatigue profile in the SOL of diseased myogenic Tg males was similar to that of the 97Q EDL, with little apparent loss in force overall during the period of fatiguing stimulation. Nonetheless, the diseased SOL in myogenic Tg males fatigued faster, at least initially, because it reached a 50% drop in force sooner than WT SOL (Tg vs. WT: 9.8 Ϯ 0.9 s vs. 42.1 Ϯ 2.4 s, P Ͻ 0.05).
Few Signs of Histopathology Despite Robust Muscle Dysfunction
Finding muscle dysfunction in both the 97Q and myogenic 141 Tg models prompted us to examine muscles for evidence of histopathology to evaluate whether dysfunction correlates with any known histological markers of disease. In a crosssection taken from the belly of the muscle, we counted the total number of muscle fibers and the number of fibers with centralized nuclei in the EDL and SOL muscles of the 97Q model and the SOL muscle of the myogenic model. The EDL muscle from 141 myogenic males was previously analyzed in the same way (19) .
97Q model. Even though the EDL muscles from diseased 97Q males was about one-half the mass of those from WT males (Table 1) , the number of EDL fibers did not differ significantly between diseased and healthy muscles (Fig. 6) . Measuring the diameter of fibers in the same muscle cross- Values are means Ϯ SE in ms. Only rise time (time to peak force) in the EDL muscle of 141 Tg males was significantly prolonged compared to WT controls. Note a consistent trend toward slower twitch kinetics in diseased muscles of both models. *P Յ 0.05. Fig. 2 . Both fast-twitch extensor digitorum longus (EDL) and slow-twitch soleus (SOL) muscles of motor-impaired 97Q Tg males show deficits in contractile force. Raw twitch and tetanic force (A, D, and G) were significantly reduced, with the one exception that raw tetanic force was unaffected in the SOL (J). Once normalized to muscle mass, both twitch and tetanic forces were significantly reduced in both muscles (B, E, H, and K), indicating primary defects in contractile function of 97Q muscles that are independent of mass. The force deficit is also readily apparent in examples of individual twitch traces of EDL (C) and SOL (I). The twitch-to-tetanus (Tw/Tet) ratio for the SOL (L) but not the EDL (F) was significantly reduced in diseased 97Q males, suggesting defects in calcium handling mechanisms may contribute to defects in motor function. *P Յ 0.05 compared with WT controls. Values are means Ϯ SE, with n ϭ 4 -7 mice/group. section used to count fibers confirmed that EDL muscle fibers in Tg males were on average 25% smaller compared with EDL fibers in age-matched WT males (P Ͻ 0.028). Some EDL fibers in the cross-section were also visibly atrophic (Fig. 6) . Regardless, force capacity of the diseased EDL of the 97Q males was about six times less than that of WT EDL, even when differences in muscle mass were taken into account (Fig.  2) , indicating that fiber size alone cannot explain the loss of intrinsic strength. The SOL muscle from 97Q males looked remarkably normal when viewed in cross-section (Fig. 6) . Morphometric analyses revealed that the SOL also contained a normal number of fibers (Fig. 6) , paralleling in this case its normal mass (Table 1 ). We also found that the mean size of SOL fibers was unaffected by disease, having the same diameters in cross-section as WT fibers (P ϭ 0.498). Also, disease did not increase the number of SOL fibers with centralized nuclei (Fig. 6 ). In short, we saw no evidence of classic histological markers of neuromuscular disease in the SOL muscle, despite this muscle being significantly weaker in 97Q motor-impaired mice. In contrast, significantly more EDL fibers in 97Q males contained centralized nuclei compared with EDL fibers in WT males (Fig. 6 ), paralleling the greater force deficit caused by disease in this muscle compared with the SOL of 97Q males.
141 Myogenic model. Previous work showed that the EDL of myogenic males contains about one-third fewer fibers than WT EDL (19) . In contrast, the SOL of 141 diseased Tg males showed no difference in total fiber number (Fig. 6 ) even though its mass was significantly less than WT SOL (Table 1) , suggesting that SOL muscle fibers in the myogenic model are generally smaller than normal, but with a notable lack of atrophic fibers (Fig. 6) . The diseased SOL of 141 males, however, contained a significantly higher proportion of fibers with centralized nuclei than WT SOL (Fig. 6 ). This was not the case for the myogenic EDL (Johansen and Jordan, unpublished data). Interestingly, the incidence of centralized nuclei in both Fig. 4 . Both the EDL and SOL of motor-impaired myogenic (141) Tg males show significant deficits in contractile force. Raw and normalized twitch forces were significantly reduced in both the EDL and SOL of motor-impaired Tg males (A, D, G, and J). Raw and normalized tetanic forces followed the same pattern with the one exception that normalized tetanic force in Tg EDL (E) was unaffected. Because the myogenic EDL contains significantly fewer fibers (see Fig 7) , the deficit in raw tetanic force in the EDL probably reflects the deficit in fiber number in this muscle. Representative samples of twitch traces demonstrate such deficits in twitch force (C and I). The twitch-to-tetanus ratio is also significantly reduced in both the Tg EDL (F) and SOL (L), suggesting that calcium mobilization from intracellular stores may also be perturbed in diseased muscles of the myogenic model. *P Յ 0.05 compared with WT controls. Values are means Ϯ SE, with n ϭ 4 -7 mice/group. Fig. 3 . Both the EDL and SOL from motor-impaired 97Q Tg males fatigue more rapidly. While the Tg EDL loses less of its original force than the WT EDL overall (A), the Tg EDL appears to fatigue faster, losing 50% of its original force (time to one-half of maximal force loss) significantly sooner than WT EDL (B). The Tg SOL also has a faster time course of fatigue than WT SOL, losing 50% of its original force significantly sooner than WT SOL (D). *P Յ 0.05 compared with WT controls. Values are means Ϯ SE, with n ϭ 4 -7 mice/group. models seems to correspond to the most severe force deficit, with the EDL in the 97Q model and the SOL in the myogenic 141 model. However, because force deficits can occur in some muscles in the absence of overt fiber atrophy or centralized nuclei, these histopathological indices of SBMA likely reflect the effects of disease in specific muscles and models.
KI model. Although KI mice displayed clear deficits in motor function, with both forelimb grip strength and hang (141) diseased males. The Tg EDL loses less total force than WT EDL overall (A), consistent with the disease-related increase in oxidative metabolism in this muscle, making this muscle more resistant to fatigue (19, 34) . On the other hand, both Tg and WT EDL appear to fatigue at about the same rate, reaching a 50% drop at about the same time (B). The SOL of diseased 141 Tg males fatigues rapidly, losing 50% of its starting force in Ͻ10 s compared with ϳ40 s in WT SOL. This marked increase in fatigue susceptibility of the SOL likely contributes to motor dysfunction in this model. *P Յ 0.05 compared with WT controls. Values are means Ϯ SE, with n ϭ 4 -6 mice/group. times significantly less compared with WT controls (Fig. 7, A and B; grip P Ͻ 0.002; hang P Ͻ 0.03), contractile force produced by the hindlimb EDL was marginally decreased, while unaffected in the SOL of KI males (Fig. 7, C-N) . The twitch kinetics of the EDL and SOL were not affected by disease in KI males (data not shown).
Deficits in Chloride Channel Expression and Resting Membrane Potential May Be a Core Disease Phenotype of SBMA
Although we did not detect significant force defects in hindlimb muscles of KI mice, muscles in this model are reportedly hyperexcitable and showed a depletion of surface membrane chloride channels, particularly evident in the ARrich levator ani (53) . These disease-related defects are also evident in muscles affected by the primary myopathy DM1 (30) . Diseased muscle fibers are partially depolarized at rest (by 10 -20 mV), contributing to the hyperexcitability of the diseased muscle. We explored whether these pathological traits of DM1 are evident across different SBMA models by measuring the resting membrane potential of muscle fibers and assessing the expression of CLCN1 mRNA for the muscle chloride channel.
As expected, we found that the resting membrane potential of muscle fibers in diseased KI males was significantly decreased (by ϳ14 mV) compared with WT fibers of matched controls (Table 3) . Importantly, we found the same deficit in the 97Q and myogenic models. In both Tg models, the resting membrane potential of EDL fibers were also significantly shifted to a less polarized potential (ϳ14 -17 mV) compared with their respective WT EDL fibers.
Based on RT-qPCR, we also found significant deficits in chloride channel mRNA in the muscles of both the Tg models (Table 3) . Although a twofold deficit in chloride channel mRNA was also found in the muscle of KI males, this difference was short of significance but nonetheless consistent with A and B) . While force measures in the KI EDL suggest small deficits in twitch and tetanic force consistent with the mild motor phenotype in this model, these apparent deficits are not significant (C-H). We found no significant deficits in twitch and tetanic forces produced by the SOL from KI males (I-N). These data raise the possibility that motor deficits in KI males may reflect synaptic defects upstream of the skeletal muscles that may precede muscle dysfunction. *P Յ 0.05 compared with WT controls. Values are means Ϯ SE, with n ϭ 5-7 mice/group. Values are means Ϯ SE unless otherwise noted. *Mean resting membrane potential (RMP) is based on n ϭ no. of junctions from N ϭ no. of animals/genotype. †Relative to WT control males of the same colony as diseased males and based on N ϭ 6 -7 mice/group. KI, knock-in; LA, levator ani. P ϭ 0.001, WT vs. Tg. a previously reported deficit in the KI model (53) . These data showed for the first time comparable defects in the muscles of three different SBMA mouse models, raising the strong possibility that hyperexcitability of muscle fibers and depletion of membrane chloride channels may be core defects in the muscles of SBMA patients.
DISCUSSION
SBMA causes a disabling loss of motor function that profoundly degrades quality of life. While long assumed to be a disease of the motoneurons, recent data challenge this view and redirect attention to skeletal muscles as targets of disease. For example, a disease-causing AR transgene expressed only in skeletal muscle induces an SBMA phenotype characterized by a male-biased loss of motor function and motoneuron pathology (7, 24, 34) . Equally compelling is rescuing motor function and life span by lowering levels of mutant AR in skeletal muscles but not in the spinal cord of two different SBMA mouse models (28) . However, studies aimed at understanding how SBMA affects muscle function are lacking. Thus we set out to determine whether skeletal muscles from diseased male mice of three different SBMA models show dysfunction, assessing the contractile properties in vitro of the canonical fast-and slow-twitch muscles, EDL and SOL. Two of the models, the KI and 97Q Tg models, each broadly expresses a mutant AR allele linked to SBMA (22, 53) , while the third myogenic (line 141) model expresses rat WT AR only in skeletal muscle fibers but nonetheless recapitulates the same male-biased, androgen-dependent loss of motor function as the other two models (34) . We found that the EDL and SOL of both Tg models showed striking deficits in contractile force and fatigue resistance, correlating with the loss of motor function behaviorally. Hindlimb muscles of KI males showed only subtle deficits in force production, in agreement with the generally more benign phenotype in this model. However, given that KI muscles are reported to be hyperexcitable and depleted of membrane chloride channels, similar to muscles of DM1 (53, 54), we explored whether such defects were in fact a general characteristic of SBMA mouse models, and our data confirm that notion. Intracellular measures of the resting membrane potential of muscle fibers and RT-qPCR measures of chloride channel (CLCN1) mRNA revealed that fibers in all three models were significantly depolarized (by ϳ14 -17 mV) and expressed less CLCN1 mRNA. We are the first to directly examine the function of skeletal muscles isolated from the nervous system in any SBMA model, and our findings support the hypothesis that primary muscle dysfunction may underlie motor dysfunction in SBMA.
It is important to point out that motor dysfunction could also result from dysfunction upstream of the muscle, such as at the neuromuscular synapse, or possibly reflect a combination of synaptic and muscle dysfunction. Although our results indicate that muscle dysfunction could potentially fully account for the loss of motor function, they do not rule out the possibility that there is also synaptic dysfunction. Indeed, that muscle force is not significantly affected in KI males despite reduced motor performance points to dysfunction upstream of the muscle as another potential contributor of motor dysfunction in SBMA. Regardless, a systematic assessment of both synaptic and muscle function in neuromuscular preparations from multiple SBMA mouse models is needed to tease apart whether motor dysfunction in SBMA patients may be caused by dysfunction at the synapse and/or the muscle.
There are several possible explanations for why muscles of KI males did not show significant defects in contractile properties despite impaired motor function. The most obvious possibility is that the motor tests used, hang and grip strength, reflect defects in muscles other than the EDL and SOL. Since grip strength was based on forepaw grip, it tests the function of only forelimb and not hindlimb muscles. Moreover, disease susceptibility seems to vary in the KI model depending on the specific muscle (53) . Because perineal muscles are enriched for AR (18, 35) , these muscles are affected first and more severely in KI males than limb muscles. Hence, it is possible that marked dysfunction would have been detected if perineal muscles had been studied rather than the EDL and SOL. Another possibility is that presynaptic dysfunction underlies the loss in motor function in KI males with the muscles themselves functionally intact. Previous work in KI males indicated retrograde axonal transport is severely impaired (24) , establishing that motoneurons are indeed dysfunctional in KI males. Because defects in axonal transport are often associated with defects in nerve terminal function (42) , KI males may well have impairments in synaptic function. Such observations would be consistent with clinical reports of defects in neuromuscular transmission in SBMA patients (16, 32, 36) . Finally, the apparent deficits in muscle strength suggested by shortened hang times and reduced grip strengths may reflect nonspecific effects of the KI allele in mice. Dysfunction of the perineal muscles in KI males causes uremia and early morbidity (53) . Poor motor performance could reflect effects of this condition rather than direct toxic effects of AR on limb muscle function. Regardless, these data underscore the fact that defects in motor function do not always correspond to significant defects in muscle contraction.
What Is the Nature of the Muscle Dysfunction?
Muscle atrophy triggered by the loss of innervation has long been assumed to underlie the progressive loss of muscle strength in SBMA. Current data do not support this view. While muscles from both 97Q and myogenic 141 male mice generally have less mass and produce less absolute force than muscles from WT controls, we found significant deficits in twitch and tetanic force even when normalized to muscle weight (Figs. 2 and 4) , indicating that muscle atrophy accounts for only a small portion of the loss in contractile strength. The one exception is the myogenic EDL in which a deficit in raw tetanic force is eliminated once muscle mass is taken into account. However, this muscle is the only muscle examined so far from SBMA mouse models that contains significantly fewer muscle fibers (19) , suggesting that this deficit in raw tetanic force reflects the deficit in EDL fiber number. These data generally point to mechanisms other than those controlling muscle mass (such as atrogin-1 and myostatin) as targets for disease underlying the loss of muscle strength in SBMA.
How toxic AR causes a loss in contractile force is not clear and warrants future study. A microarray study of gene changes in hindlimb muscle from these same models suggests possible candidate molecules (33) . For example, calpain 2 is upregulated in hindlimb muscles of both 97Q and myogenic Tg males but not KI males. Calpain 2 is a calcium-dependent protease which resides in the sarcoplasm of muscle fibers (reviewed in Ref. 50 ) and is thought to be an important player in promoting muscle atrophy (49) . Although enhanced calpain activity may account for a loss of muscle strength due to atrophy, it may also be involved in regulating muscle strength independent of mass. Calpain promotes the activity of caspase 3 (49), with caspase 3 activity during sepsis implicated in the rapid loss of force without losses in mass (48) .
Calcium-handling mechanisms are also plausible targets of disease, given the disease-related changes in the twitch-totetanus ratio and twitch kinetics we see in diseased muscle. The ryanodine receptor, troponin C and the sarco/endoplasmic reticulum Ca 2ϩ -ATPase releases, binds to and sequesters intracellular calcium in muscle, respectively (51) . Defects in the function of the ryanodine receptor, a critical player in the excitation-contraction pathway, seems particularly likely given recent evidence from acutely diseased Tg 141 females (10, 38) . Given the androgen-dependence of SBMA, an important criterion for any pathogenic mechanism implicated in muscle dysfunction is whether it is reversible when androgens are removed.
Trophic factors may also be involved in regulating muscle strength. One molecule of particular interest is IGF-I. In addition to mediating anabolic effects of androgens on skeletal muscle (13) , IGF-I has also been implicated in SBMA. When overexpressed exclusively in skeletal muscle, IGF-I rescues 97Q mice from disease (39) . IGF-I expression is also lower in muscles of affected KI males (53) . While studies often focus on the effects of muscle-derived trophic factors on motoneurons, the role of such factors in regulating muscle function merits further attention, particularly because skeletal muscles express the receptors for many muscle-derived trophic factors including IGF-I (6).
One significant aspect of these data is that losses in force can occur without significant histopathology. For example, the SOL in the 97Q males has compromised function but appears largely protected from disease based on morphological attributes: its mass is unaffected (Table 1) , the number and size of SOL muscles fibers is normal (Fig. 6) , and the frequency of fibers with centralized nuclei is also normal (Fig. 6) . Despite the lack of histopathology, the SOL generates significantly less twitch and tetanic force (Fig. 2, H and K) , has a reduced twitch-to-tetanus ratio (Fig. 2L) , and fatigues more rapidly, losing one-half its starting force sooner than normal SOL (Fig.  3D) . The SOL in myogenic males presents a similar picture, although its function is even more severely affected. Although stained cross-sections of SOL look remarkably normal, with fibers appearing relatively uniform in size, albeit smaller, and fiber number normal (Fig. 6) , the diseased SOL produces only a small fraction (ϳ30%) of the force produced normally (Fig.  4, H and K) . The only apparent morphological correlate of muscle dysfunction that we found was the incidence of fibers containing centralized nuclei. Muscles with the greatest force deficit in each model (EDL in the 97Q males and SOL in the myogenic males) also showed a disease-related increase in the prevalence of fibers with centralized nuclei. However, the significance of this relationship is not clear, because some muscles clearly lose force without a corresponding increase in the frequency of centralized nuclei. The marked absence of histopathology in diseased muscle has also been reported for another mouse model of SBMA (5) and reinforces the likelihood that cellular dysfunction precedes disease-related changes in cell morphology.
While motor function appears comparably affected in the two Tg models, the severity of the deficit in force differed for given muscles in each model. The EDL was more severely affected in the 97Q model while the SOL was more severely affected in the myogenic 141 model. Given that the EDL is a fast-twitch muscle while the SOL is a slow-twitch muscle, these results suggest that the toxic potential of AR in each model depends on the fiber type composition of the muscle, although the factors behind this fiber type dependence are not clear. Fiber type differences have also been found to play a role in amyotrophic lateral sclerosis models where fast-twitch motor units are more severely affected (1, 15) . One possible explanation for the differing susceptibilities to disease is that the level of AR expression also varies, paralleling the more toxic effects in select muscles. We think this explanation is unlikely. In the myogenic model, for example, we found the same pattern of deficits in acutely diseased Tg females, with force being more severely affected in the SOL than in the EDL, but these muscles showed comparable AR expression (38) . Although enhanced AR expression might explain the greater force deficits in the EDL than the SOL of 97Q males, it does not readily account for the other functional deficits such as in the twitch-to-tetanus ratio seen in the SOL but not the EDL of 97Q males. Microarray data also offer a possible explanation. The slow isoform of troponin C, which binds calcium to trigger skeletal muscle contractions, is downregulated in the hindlimb muscle of only myogenic 141 males, potentially underlying the more severe loss of force in 141 Tg SOL. However, because the force deficit is fully established within 3 days of disease onset in the SOL of acutely diseased 141 Tg females, the greater than 5-day half-life of slow troponin C (31) challenges this idea.
Skeletal muscles of affected 97Q and myogenic 141 Tg males may also have altered metabolic properties, as suggested by the fatigue data. The EDL of myogenic Tg males exhibited greater resistance to fatigue than WT controls, losing less total force over the course of the experiment (Fig. 5A) . These data are consistent with previous findings of a more oxidative profile in Tg EDL (10, 34) . The SOL of myogenic Tg males, on the other hand, exhibited little drop in force output with repeated stimulation, but we suspect this is because force output was near basement to begin with (Fig. 4, H and K) . Nonetheless, what force was lost occurred at a faster rate, with the SOL from 141 Tgs losing 50% of its original force about four times faster than WT SOL. Both the EDL and SOL muscles of 97Q males showed less resistance to fatigue compared with WT controls (Fig. 3) . While mitochondrial function in muscles of 97Q mice have not been studied, the effects of the 97Q AR transgene in neuron-like cell cultures suggest that mitochondria are defective in 97Q muscles (43) .
Is SBMA a Form of Myotonic Dystrophy?
Studies of myotonic dystrophy may shed light on the mechanisms underlying muscle weakness and dysfunction in SBMA, since both show similar symptomology (53, 54) . For example, both diseases involve proximal and distal muscle weakness, fasciculations, and wasting. Interestingly, both are also characterized by elevated levels of plasma creatine kinase as well as testicular dysfunction (21, 44) . Moreover, both show some of the same missplicing events (29, 54) . For example, splicing of the preRNA for the chloride channel in skeletal muscle is impaired, introducing a premature stop codon that leads to nonsense RNA, causing chloride channels to be largely absent from the fiber membrane. With chloride channels depleted, the resting membrane potential is also reduced, and muscle fibers are hyperexcitable (30) . We found a comparable drop in the resting membrane potential of diseased muscle fibers of all three SBMA models (Table 3 ). We also found that diseased muscles of both 97Q and myogenic SBMA males showed a 3.5-to 5-fold drop in CLCN1 mRNA, corresponding to a previously reported deficit in CLCN1 mRNA expression in diseased SBMA KI muscles (53, 54) . While finding a deficit in CLCN1 mRNA in our muscle samples from KI males, this deficit fell short of significance (Table 3) , possibly due to the shorter repeat length in AR expressed by our KI males than in the prior report. Nonetheless, these pathological features are strikingly similar to DM1 (4, 30) and suggest that the same pathogenic mechanisms causing weakness and wasting of skeletal muscles in DM1 may also be relevant to SBMA and warrants future attention to better understand the parallels between these two diseases.
In conclusion, the current work suggests that primary defects in muscle function may underlie the loss of motor function in SBMA. Consistently finding elevated levels of serum creatine kinase in SBMA patients also implicates muscle as a primary site of AR action in this disease (2, 3, 46, 47) . Our findings are also consistent with several other reported findings implicating skeletal muscle as a primary contributor in motoneuron disease (9, 19, 25, 34, 39, 40, 52, 53) .
In summary, data from isolated fast-and slow-twitch muscles indicate that defects in skeletal muscle function may contribute to deficits in motor function in SBMA. While deficits in muscle strength may well reflect reductions in mass, significant losses in strength were observed independent of muscle mass. In short, muscles need not lose mass to lose strength. Diseased muscles from SBMA models are also generally more susceptible to fatigue. Finally, we found that muscle fibers of all three models showed evidence of hyperexcitability, probably due to a loss of chloride and other voltage-gated membrane channels. We propose that this particular defect in skeletal muscles likely precedes the loss in strength and may well be the source of chronic muscle fasciculations and cramping experienced preclinically in SBMA. Future studies aimed at developing therapies to protect muscles from the toxic effects of AR may offer significant benefits to SBMA patients.
